HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amniotic fluid interleukin-6 and neutrophil gelatinase-associated lipocalin for predicting fetal inflammatory response syndrome based on histological chorioamnionitis and funisitis.

AbstractOBJECTIVE:
We aimed to analyze the predictive efficacy of amniotic fluid interleukin-6 (IL-6) and neutrophil gelatinase-associated lipocalin (NGAL) for fetal inflammatory response syndrome (FIRS)-related infection.
MATERIALS AND METHODS:
We included singleton pregnancies classified into FIRS and non-FIRS groups. FIRS was defined as histologic chorioamnionitis and funisitis. Amniotic fluid samples were collected during vaginal delivery (VD) or cesarean section (CS). We compared amniotic fluid IL-6 and NGAL levels between the groups.
RESULTS:
Forty-six pregnancies were analyzed and classified into 20 (43.5%) FIRS and 26 (56.5%) non-FIRS pregnancies. We observed significant differences in amniotic fluid IL-6 and NGAL. Amniotic fluid collection significantly influenced NGAL levels (p < 0.001). The area under the concentration-time curve (AUC), with optimal cutoff values, for amniotic fluid IL-6 and NGAL (VD and CS) levels was 0.948 (11,344 pg/mL), 0.800 (1180 ng/mL), and 0.946 (708 ng/mL), respectively.
CONCLUSION:
Amniotic fluid IL-6 and NGAL levels showed equivalent predictive ability for FIRS-related infection.
AuthorsDaisuke Katsura, Shunichiro Tsuji, Kaori Hayashi, Shinsuke Tokoro, Takako Hoshiyama, Nobuyuki Kita, Takashi Murakami
JournalTaiwanese journal of obstetrics & gynecology (Taiwan J Obstet Gynecol) Vol. 62 Issue 4 Pg. 516-520 (Jul 2023) ISSN: 1875-6263 [Electronic] China (Republic : 1949- )
PMID37407186 (Publication Type: Journal Article)
CopyrightCopyright © 2023. Published by Elsevier B.V.
Chemical References
  • Interleukin-6
  • Lipocalin-2
Topics
  • Pregnancy
  • Humans
  • Female
  • Chorioamnionitis (diagnosis)
  • Interleukin-6
  • Amniotic Fluid
  • Lipocalin-2
  • Cesarean Section

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: